Finance

Beta
Senarai
Sektor ekuiti
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Buka
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
ORNBV:HEL
Orion Oyj Class B
€68.70
+4.09%
(+2.70) 1H
30 Apr, 6:29:55 PTG GMT+3  ·   EUR
Semua simbol
SimbolPriceChange% Change
Generating top insights for ORNBV...
Buka
€66.25
High
€68.70
Low
€65.90
Mkt. cap
9.58B
Avg. vol.
187.24K
Volume
283.65K
Dividend
2.62%
Quarterly dividend
€0.45
Ex dividend date
15 Okt 2025
P/E ratio
18.25
52-wk high
€75.30
52-wk low
€51.55
EPS
€3.76
Shares outstanding
109.61J
No. of employees
4K
News stories
From sources across the web
Profil
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland. Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
About Orion Oyj Class B
CEOLiisa Hurme
Employees4.13K
Founded21 Sep 1917
Headquarters-
Sector-
Websiteorionpharma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dis 2025
Mac 2026
Revenue
416.50J
423.20J
695.30J
417.70J
Cost of goods sold
168.10J
169.00J
186.60J
163.70J
Cost of revenue
168.10J
169.00J
186.60J
163.70J
Research and development expenses
49.10J
49.80J
70.60J
48.30J
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
96.70J
84.60J
110.30J
91.90J
Operating expense
143.70J
133.20J
180.40J
139.30J
Total operating expenses
311.80J
302.20J
367.00J
303.00J
Operating income
104.70J
121.00J
328.30J
114.70J
Other non operating income
-100.00K
-
-500.00K
100.00K
EBT including unusual items
103.40J
120.40J
327.10J
113.40J
EBT excluding unusual items
103.40J
120.40J
327.30J
113.40J
Income tax expense
20.90J
24.40J
66.60J
23.00J
Effective tax rate
20.21%
20.27%
20.36%
20.28%
Other operating expenses
-2.10J
-1.20J
-500.00K
-900.00K
Net income
82.50J
96.00J
260.50J
90.40J
Net profit margin
19.81%
22.68%
37.47%
21.64%
Earnings per share
0.59
0.68
1.85
0.64
Interest and investment income
-
-
4.60J
-
Interest expense
-1.20J
-600.00K
-5.40J
-1.40J
Net interest expenses
-1.20J
-600.00K
-800.00K
-1.40J
Depreciation and amortization charges
-
-
-
-
EBITDA
118.70J
135.10J
336.50J
130.40J
Gain or loss from assets sale
-
-
100.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

Tugasan saya
Anda belum membuat tugasan lagi
Tugasan anda akan dipaparkan di sini. Jadualkan tugasan dan manfaatkan Google Finance semasa anda tiada.
Templat
Ringkasan senarai amatan
Analisis prapasaran harian bagi senarai amatan anda
Pendapatan Akan Datang
Laporan pendapatan akan datang dalam minggu ini
Kemudahubahan & Jumlah yang Tidak Normal
Amaran awal kemudahubahan dan jumlah hari ini
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer